FLUPHENAZINE Drug Patent Profile
✉ Email this page to a colleague
When do Fluphenazine patents expire, and what generic alternatives are available?
Fluphenazine is a drug marketed by Eugia Pharma, Fresenius Kabi Usa, Gland, Hikma, Hospira, MSN, Mylan Labs Ltd, Ph Health, Teva Parenteral, Ani Pharms, Pharm Assoc, Ajanta Pharma Ltd, Alembic, Amneal, Apotex, Aurobindo Pharma Ltd, Breckenridge, Dr Reddys, Glenmark Pharms Ltd, Hetero Labs Ltd Iii, Lannett Co Inc, Novitium Pharma, Prasco, Rising, Sandoz, Taro, Torrent, Twi Pharms, Upsher Smith Labs, Watson Labs, Zameer Pharms, and Zydus Lifesciences. and is included in thirty-nine NDAs.
The generic ingredient in FLUPHENAZINE is fluphenazine hydrochloride. There are nineteen drug master file entries for this compound. Twenty-nine suppliers are listed for this compound. Additional details are available on the fluphenazine hydrochloride profile page.
DrugPatentWatch® Litigation and Generic Entry Outlook for Fluphenazine
A generic version of FLUPHENAZINE was approved as fluphenazine hydrochloride by FRESENIUS KABI USA on April 16th, 1987.
AI Deep Research
Questions you can ask:
- What is the 5 year forecast for FLUPHENAZINE?
- What are the global sales for FLUPHENAZINE?
- What is Average Wholesale Price for FLUPHENAZINE?
Summary for FLUPHENAZINE
| US Patents: | 0 |
| Applicants: | 32 |
| NDAs: | 39 |
| Drug Prices: | Drug price information for FLUPHENAZINE |
| DailyMed Link: | FLUPHENAZINE at DailyMed |
